On Point with Meghna Chakrabarti

Lessons from America’s peanut allergy flip-flop

Nov 3, 2025
Dr. Robert Wood, Chief of Pediatric Allergy and Immunology at Johns Hopkins, and Dr. David Hill, a pediatric allergist at the Children's Hospital of Philadelphia, dive deep into the puzzling rise of peanut allergies in the U.S. They reveal how past avoidance recommendations backfired, leading to increased prevalence. The LEAP study shows that early introduction can drastically reduce allergy risk. They discuss the evidence behind public health guidance and caution against attributing allergy trends to single factors, emphasizing a balanced approach in allergen introduction.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

One Sentence Became National Dogma

  • The AAP's 2000 statement targeted high-risk infants but included one sentence delaying peanuts until age three.
  • That limited guidance became widely generalized into blanket avoidance for all infants, shaping practice for years.
ANECDOTE

A Family Reshaped By One Allergy

  • Lisa Rutter describes discovering her son Evan had a severe peanut allergy that dominated family life.
  • She had to overhaul the pantry, demand nut-free school spaces, and carry an EpiPen everywhere.
INSIGHT

LEAP Changed The Evidence Base

  • The LEAP randomized trial showed early peanut introduction reduced peanut allergy by about 85%.
  • That high-quality evidence overturned the avoidance hypothesis and spurred new guidelines.
Get the Snipd Podcast app to discover more snips from this episode
Get the app